laboratory biomarker analysis [clinicaltrials_resource:35ea7533bbf81701a9ec3c4284bff487]
Bortezomib in Treating Children With Advanced Solid Tumors [clinicaltrials:NCT00021216]clinicaltrials:NCT00023712PS-341 in Treating Patients With Metastatic Malignant Melanoma [clinicaltrials:NCT00024011]PS-341 in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00025584]Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction [clinicaltrials:NCT00054483]Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer) [clinicaltrials:NCT00077441]
intervention [clinicaltrials_vocabulary:intervention]
laboratory biomarker analysis [clinicaltrials_resource:35ea7533bbf81701a9ec3c4284bff487]
Bio2RDF identifier
35ea7533bbf81701a9ec3c4284bff487
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:35ea7533bbf81701a9ec3c4284bff487
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
Correlative studies
intervention name [clinicaltrials_vocabulary:intervention-name]
laboratory biomarker analysis
identifier
clinicaltrials_resource:35ea7533bbf81701a9ec3c4284bff487
title
laboratory biomarker analysis
@en
type
label
laboratory biomarker analysis [clinicaltrials_resource:35ea7533bbf81701a9ec3c4284bff487]
@en